Announcements Trials
Browse Landscape

Phase

Phase 2 93Phase 1 23Phase 1/2 13Phase 3 9Phase NA 3Phase EARLY_PHASE1 3Phase 4 3Phase 2/3 3

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 2Carcinoma, Renal Cell 1

Interventions

Magnetic Resonance Spectroscopy 59Cyclophosphamide 44pembrolizumab 34Radiotherapy 30fludarabine 27Nivolumab 26Biopsy 26Metformin 22Fluorodeoxyglucose F18 22Specimen Handling 20Bevacizumab 20Temozolomide 17Radiosurgery 17Cisplatin 16Carboplatin 14Fluorouracil 13Dexamethasone 13Paclitaxel 12Gemcitabine 12Etoposide 12gallium 68 PSMA-11 11durvalumab 11X-Rays 11Surgical Procedures, Operative 11Radiation 11Positron Emission Tomography Computed Tomography 11Letrozole 11Irinotecan 11Ipilimumab 11Surveys and Questionnaires 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × enzalutamide × Clear all
NCT05683964 2026-02-13

Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression

Beth Israel Deaconess Medical Center

Phase EARLY_PHASE1 Active not recruiting
9 enrolled
Genitourinary

Prostatic Neoplasms

NCT03734653 2025-11-06

Testosterone Therapy in Castration Resistant Prostate Cancer

University of Colorado, Denver

Phase EARLY_PHASE1 Completed
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT02885649 2021-09-16

Enzalutamide Before Surgery in Treating Patients With Kidney Cancer

Rutgers, The State University of New Jersey

Phase EARLY_PHASE1 Terminated
3 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡